System | Type | Disorder | Pubmed |
cancer | | | |
inhibition of a tyrosine kinase/TIGAR/NADPH cascade may have therapeutic applicability in human cancers |
cancer | digestive | colon | |
potential therapeutic target in diseases such as intestinal cancer |
immunology | inflammatory | | |
potential therapeutic target in diseases such as ulcerative colitis |
neurology | epilepsy | | |
promising therapeutictarget for epilepsy |
cancer | hemopathy | | |
combination of TIGAR inhibitors with anti-glycolytic agents may be novel therapies for the future clinical use in AML (acute myeloid leukemia) patients |
cancer | | | |
could serve as a potential target for the development of effective antineoplastic therapies |